# Ophthalmic and Topical Dosage Form New Animal Drugs; Emodepside and Praziquantel
> **Food and Drug Administration** · Final rule. · Published 2007-08-02 · Effective 2007-08-02 · 72 FR 42291
## Document
- **Document number:** E7-14945
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 42291
- **CFR reference:** 21 CFR 524
- **Publication date:** 2007-08-02
- **Effective date:** 2007-08-02
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Bayer HealthCare LLC. The NADA provides for veterinary prescription use of an emodepside and praziquantel topical solution on cats for the treatment and control of infections by several internal parasites.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/08/02/E7-14945/ophthalmic-and-topical-dosage-form-new-animal-drugs-emodepside-and-praziquantel)
---
*AI Analytics · CC0 1.0*